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Grace Dunford, Brian Kinsman, Max Meltser, and 
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Lake Forest College 
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Summary  
 
p75NTR is an important neurotrophin receptor and plays 
a crucial role in many diverse functions in neurons. In 
the peripheral nervous system (PNS), p75NTR is known 
to enhance myelin formation and promote regeneration 
when it binds to various neurotrophins. However, in the 
central nervous system (CNS), p75NTR expression 
affects neuron survival in contrasting fashions 
depending on the ligand it binds and the other receptors 
with which it interacts. Recent evidence points to 
p75NTR as a potential neuron survival promoting 
receptor when activated in tandem with the apoptotic 
p75NTR pathway induced by NGF and nitric oxide (NO). 
Whether p75NTR expression can promote neuron 
survival or regeneration in a growth inhibitory and 
apoptotic environment such as the CNS remains 
unknown. We hypothesize that over-expression of 
p75NTR will increase neuron survival under otherwise 
apoptotic and growth inhibitory conditions. To support 
this hypothesis, we will over- and under-express 
p75NTR in CNS and PNS neurons both in vitro and in 
vivo. In vitro experiments will apply PNS and CNS 
specific neuron cultures with siRNA induced p75NTR 
under-expression or promoter induced p75NTR over-
expression in the presence and absence of p75NTR 
ligands. In vivo experiments will apply a tetracycline 
induced Cre/LoxP mouse model to over and under 
express p75NTR and its ligands in both PNS and CNS. 
We will measure neuron survival using azino-bis 
(ethylbenzothiazoline-6-sulphonic acid) enzyme-linked 
immunoabsorbant assay and the CellTiterGlo ATP 
assay. Our experiments should reveal a possible means 
of preventing CNS neuron death in cases of injury or 
neurodegeneration.  
 
Introduction 
 
Damage of the central nervous system (CNS) is among the 
most debilitating of ailments, made worse by the inability of 
tissue to repair itself. Neurons have limited ability to replace 
damaged axons and dendrites caused by injury or disease. 
Nervous tissue is virtually incapable of neurogenesis, and 
adult neurons rarely grow new axons once damaged 
(Bolsover, Fabes, and Anderson, 2008). An exception is the 
regrowth and reinnervation of peripheral axon specializations 
in the skin or at neuromuscular junctions (Temporin, et al., 
2008). Three primary barriers restrain regenerative capacity. 
Foremost, local injury to brain tissue often results in cell 
death. Second, aggregation of glial cells at the injury site 
actively inhibits axon growth over long distances. Lastly, 
adult neural stem cells possess limited ability to divide, 
migrate, and differentiate. Still, phenomena illustrating 
nervous system repair lend credence to the scientific pursuit 
of inducing nervous system regeneration.  
Neuroregeneration is the repair of nervous tissues 
________________________________________________  
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and cells (Zheng, 2005). The mechanisms underlying 
regeneration include re-myelination, generation of new 
neurons, glial cells, lengthening of axons, and restoration of 
synapses. Neuroregeneration differs between the peripheral 
nervous system (PNS) and the CNS in the cellular 
mechanisms responsible for repair. In the PNS, regeneration 
occurs by the formation and growth of axonal sprouts 
mediated by chemotactic factors secreted from Schwann 
cells. When injury occurs, macrophages and Schwann cells 
migrate to the site and clear damaged tissue, permitting new 
axon outgrowth. In the CNS, myelin-based growth inhibitors 
(MBGIs) bind receptors such as p75NTR to prevent 
regeneration. 
Damage to the CNS occurs in several ways, 
including physical trauma, hypoxia, and neurodegenerative 
diseases such as Alzheimer’s disease (AD) and amyotrophic 
lateral sclerosis (ALS). In these neurodegenerative diseases, 
there is no regeneration of myelin, which coats the nerve 
axon, and the axons are unable to grow. Ailments caused by 
the inhibition of regeneration are often due to factors 
secreted by glial cells inhibiting axon re-myelination and 
repair. A limited regenerative response to injury exists in the 
CNS. Adult CNS axons can regenerate under suitable 
conditions, such as a growth-permissive peripheral nerve 
graft (Casaccia-Bonnefil, 1998).  However, in vivo CNS post-
injury conditions predominantly either promote apoptosis, or 
prevent neurite outgrowth. Additionally, oligodendrocytes 
express three primary growth inhibitory ligands (MBGIs) in 
the myelin sheaths they produce around CNS axons (Liu, et 
al., 2006), while PNS Schwann cells only express one 
(Domeniconi, 2002). MBGIs include Nogo-A, 
oligodendrocyte myelin glycoprotein (OMgp), and myelin 
associated glycoprotein (MAG), which is the only inhibitory 
ligand expressed in both the CNS and the PNS. Post CNS 
injury, macrophages fail to effectively clear inhibitory myelin 
debris. This results in glial cell aggregation around the injury 
site, which further inhibits outgrowth.  Previous studies have 
shown that antagonizing Nogo-A expression can facilitate 
minor axon regeneration in vitro; however, other MBGIs 
continue to block growth (Dupuis, et al., 2008).  
Identification of the MBGI receptors represents 
another possible approach towards promoting CNS 
regeneration. One such receptor is the multi-functional p75 
neurotrophin receptor (p75NTR). p75NTR is at the heart of 
key biological processes involved in neuron survival and 
death decisions, axonal growth, and responses to 
environmental stimuli (Brooke, 1999). p75NTR expression 
impacts neuron survival in contrasting fashions depending 
on the ligand it binds and the receptors with which it 
interacts. When p75NTR associates with a tyrosine receptor 
kinase (Trk), the cell binds nerve growth factor (NGF), which 
promotes neuron survival (Casaccia-Bonnefil, 1998). 
Conversely, p75NTR induces apoptosis when activated by 
NGF and nitric oxide (NO) in tandem (Casaccia-Bonnefil, 
1998; Lee et al., 2001). Furthermore, a disparate Nogo 
receptor (NgR)/p75NTR complex binds the MBGIs 
(Domeniconi, 2002; Wang et al., 2002). Most recently, 
Dupuis et al. (2008) revealed that crosstalk exists between 
the activated NGF/NO receptor complex and NgR/p75NTR 
complex to promote neuron survival under otherwise 
apoptotic conditions. 
Additionally, the p75NTR receptor complex’s post-
injury activation phenotypes differ between the CNS and 
PNS. In the PNS, p75NTR/Trk complex is most prevalent 
and is responsible for promoting neuron survival via 
neurotrophin binding (Barbacid, 1995). Upon injury to the 
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PNS nerve, p75NTR and Trk expression increases on the 
newly developed growth cone (Roux et al., 1999). However, 
the absence of OMgp and Nogo-A in the PNS could be 
responsible for lower NgR/p75NTR complex activation. 
Clearing of MAG saturated myelin debris by macrophages 
after nerve injury in the PNS alleviates inhibitory activation of 
the NgR/p75NTR complex (Domeniconi, 2002). Conversely, 
the CNS never overcomes MBGI expression to promote 
regeneration. However, to ensure neuron survival post-injury 
this could allow eventual recruitment of regeneration-
inducing trophic Trk receptors to the site of axon damage. 
We already know that dual activation of p75NTR by NGF/NO 
and MBGIs effectively promotes neuron survival (Dupuis, et 
al., 2008). Thus, we ask whether over-expression of p75NTR 
augment this neuron survival effect in the CNS and PNS. 
With this in mind, we hypothesize that the over expression of 
p75NTR in the CNS and PNS will promote neuron survival in 
vitro and induce regeneration after injury in vivo. 
 
Relevance 
  
 Each year, over two million head injuries occur in the United 
States. Of these two million, 300,000 require hospitalization, 
100,000 must live with permanent disabilities and 56,000 are 
expected to die. The disabilities and deaths caused by 
traumatic brain injuries account for about a third of all injury-
related deaths in the United States (Sosin, et al., 1991). 
Many of these permanent disabilities may be prevented if a 
therapeutic solution promoting CNS regeneration existed. 
The magnitude of trauma injuries combined with the cost of 
care and familial loss make regenerative therapy a more 
economic solution than current treatments. Thus, progress 
towards a therapeutic treatment benefits both the victims of 
CNS injury and their families. 
To progress in this field, scientists must elucidate 
the pathways mediating CNS regeneration. From there, 
clinical trials may guide an effective pharmacological 
therapy. Our basic research on the value of p75NTR 
expression in CNS regeneration will pave the road on which 
to drive development of a therapeutic solution. We firmly 
believe that p75NTR plays an integral role in facilitating 
regeneration, and that better understanding its functions will 
ameliorate the lives of countless brain trauma victims, as 
well as those of their friends and family.  
 
Specific Aims 
 
This proposal implicates a means to promote CNS neuron 
survival and regeneration post-injury according to functional 
PNS regenerative mechanisms. We confidently hold that 
elucidation of the p75NTR pathway among injured neuronal 
cells represents a valuable therapeutic target for CNS 
regeneration. Thus, we hypothesize that over-expression of 
p75NTR in the CNS and PNS will promote neuron survival in 
vitro and induce regeneration after injury in vivo. 
 
1. To manipulate expression and activation of p75NTR via 
injured in vitro CNS neuronal tissues.  
P75NTR expression will be knocked-down, knocked-out, and 
increased in three CNS cell lines, respectively using siRNA 
and an overactive CMV promoter to express p75NTR. We 
will co-culture cells with Nogo-A and oligodendrocytes to 
assess neuron survival in the presence of inhibitory ligands. 
Neuron survival will be assessed using an enzyme-linked 
immunoabsorbant assay (ABT/ELISA) and CellTiterGlo ATP 
assay. 
 
2. To manipulate expression and activation of p75 NTR via 
injured in vivo CNS mouse models:  
In conditional knockout and over-expression mouse models 
for both p75NTR and Nogo we will determine if p75NTR 
allows for regeneration in the CNS. Expression will be 
manipulated using Cre/loxP technology. Neuron survival will 
be assessed using an enzyme-linked immunoabsorbant 
assay (ABT/ELISA) and CellTiterGlo ATP assay. 
 
3. To manipulate expression and activation of p75NTR via 
injured in vitro PNS neuronal tissues:  
p75NTR expression will be knocked out and increased in 
three PNS cell lines, respectively using p75NTR siRNA and 
an overactive CMV promoter to express p75NTR. We will 
co-culture neurons with MAG and Schwann cells to assess 
neuron survival in the presence of inhibitory ligands. Neuron 
survival will be assessed using an enzyme-linked 
immunoabsorbant assay (ABT/ELISA) and CellTiterGlo ATP 
assay. 
 
4. To manipulate expression and activation of p75NTR via 
injured in vivo PNS mouse models:  
In conditional knockout and over-expression mouse models 
for both p75NTR and Nogo we will determine if p75NTR 
allows for regeneration in the PNS. Expression will be 
manipulated using Cre/loxP technology. Neuron survival will 
be assessed using an enzyme-linked immunoabsorbant 
assay (ABT/ELISA) and CellTiterGlo ATP assay. 
 
Research Design & Methods 
 
AIM 1: To manipulate p75NTR expression and activation via 
in vitro CNS cell cultures. 
1. Rationale:  Damage to the CNS induces apoptosis 
among the damaged neurons and inhibits 
regeneration. However, if we over-express 
p75NTR, neuron survival should increase due to 
greater amounts of survival promoting crosstalk 
between apoptotic and growth inhibitory p75NTR 
pathways. We will support the functionality of this 
neuron survival mechanism among primary 
hippocampal and neocortical neuron cultures, as 
well as an induced hybrid motor neuron cell line, 
NSC-34. These cultures represent extensively 
researched CNS culture types of neurons injured 
by neurodegenerative diseases such as 
Alzheimer’s and multiple sclerosis. 
2. Design and Method: We will purify primary 
hippocampal and neocortical cultures from 
anesthetized, adult mouse brains (Kerwin, et al., 
1993; DeFreitas, McQuillen, and Shatz, 2001) and 
independently culture NSC-34 cells. A COS cell 
line, which lacks p75NTR expression, will be used 
as a negative control. To establish baseline 
p75NTR expression levels using 
immunohistochemistry among cell lines, we will 
perform in situ hybridization according to 
Corriveau, et al. (1998) with rodent specific probes 
for anti-p75NTR, with an anti--actin probe as a 
positive control (DeFreitas, McQuillen, and Shatz, 
2001). 
To produce p75NTR loss of function 
cells, we will deplete p75NTR transcripts using 
siRNA sequences and plasmid transfection 
technique employed by Johnston, et al. (2007). A 
randomized siRNA sequence vector will serve as 
a negative control. Preliminary p75NTR siRNA 
experiments will reveal the appropriate 
transfection dosage to mimic PNS expression. 
These siRNA experiments will knockdown 
p75NTR expressions to PNS levels, and deplete 
p75NTR. We will confirm transfection by 
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immunoblotting with an anti-mouse monoclonal 
antibody after tagging cells with mouse anti-
p75NTR, using -actin as a positive loading 
control (Johnston, et al., 2007). Gain of function 
mutants will be produced by transfecting cell lines 
with p75NTR cDNA plasmids with overactive CMV 
promoters.  
To assess whether over- or under-
expression of p75NTR effectively promotes 
neuron survival, we will co-culture the p75NTR 
depleted and p75NTR gain of function neurons 
with exogenous sources of apoptotic factors NGF 
and NO, as well as either an artificial or natural 
source of MBGI, soluble Nogo-A or 
oligodendrocytes, respectively (Dupuis, et al., 
2008). The addition of soluble brain derived 
neurotrophic factor (BDNF) and neurotoxic kainic 
acid (KA) to cultures are respectively positive and 
negative cell survival controls (Brooke, 1999; 
Young, Bilsand, and Harper, 1999). We will 
assess neuron survival using a 2,3'-azino-bis 
(ethylbenzothiazoline-6-sulphonic acid) enzyme-
linked immunoabsorbant assay (ABT/ELISA) and 
CellTiterGlo ATP assay. We will conduct two-way 
analysis of variance (ANOVA) using SPSS 13.0 
data analysis software to compare neuron survival 
between p75NTR expression and ligand co-culture 
conditions. 
Predictions: Loss of function mutant cell lines produced by 
p75NTR siRNA knockout should have no effect on neuron 
survival under any co-culturing conditions, as no ligand could 
activate p75NTR. In p75NTR knockdown cell lines mimicking 
the PNS, reduced neuron survival should occur in all co-
cultures. This is expected due to increased probability of 
NGF and NO binding. However, among p75NTR gain of 
function cells we expect neuron survival to increase through 
increased MBGI-p75NTR binding. Contrary to our 
hypothesis, decreased cell survival upon p75NTR over-
expression would suggest greater NGF than MBGI binding 
to p75NTR. A stronger p75NTR binding affinity by NGF than 
MBGIs would explain such alternative results. 
 
 AIM 2: To manipulate expression and activation of p75 NTR 
via in vivo CNS mouse models. 
1. Rationale:  To further test p75NTR’s effect on 
neuron survival, our research uses a conditional 
knockout and over-expression mouse model for 
p75NTR and Nogo so as to examine central 
nervous system neuronal cells in vivo. The 
Cre/loxP system is a way to conditionally knockout 
or over-express genes in a site specific and time 
specific fashion to prevent lethality or other 
complications that occur in mice with conventional 
knockouts (Neumann, 1998). The Cre/lox system 
has the advantage of working in almost every type 
cell demonstrating its complete versatility and 
usefulness in this experiment.  
2. Design and Method: 
a) Injury and Analysis: Tetracycline will be injected 
into the crossed Cre/loxP mouse model one day 
prior to injury in order to induce knockout of 
p75NTR. A spinal chord dorsal hemisection (Li 
and Strittmatter, 2003) will be performed in order 
to injure the CNS of the Cre/loxP crossed mouse 
models five days after birth. 
To assess whether over- or under-
expression of p75NTR effectively promotes 
neuron survival, we will co-culture the p75NTR 
depleted and p75NTR gain of function neurons 
with exogenous sources of apoptotic factors NGF 
and NO, as well as either an artificial or natural 
source of MBGI, soluble Nogo-A or 
oligodendrocytes, respectively (Dupuis, et al., 
2008). The addition of soluble brain derived 
neurotrophic factor (BDNF) and neurotoxic kainic 
acid (KA) to cultures are respectively positive and 
negative cell survival controls (Brooke, 1999; 
Young, Bilsand, and Harper, 1999). We will 
assess neuron survival three, five and seven days 
after injury using a 2,3'-azino-bis 
(ethylbenzothiazoline-6-sulphonic acid) enzyme-
linked immunoabsorbant assay (ABT/ELISA) and 
CellTiterGlo ATP assay. We will conduct 
multivariate analysis of variance (MANOVA) using 
SPSS 13.0 data analysis software to compare 
neuron survival dependence on time, p75NTR 
expression, and ligand co-culture conditions. 
b) Cre/loxP Mouse Models:  To produce a conditional 
knockout of p75NTR in a mouse model, we will 
use the CNS growth-associated gene promoter 
(GAP-43; Zhang, 2005) with a tetracycline 
inducible Cre system (Sun, Chen, and Xiao, 2007) 
to allow for spatial and temporal control of 
p75NTR expression in vivo. In this case, a 
conditional knockout of p75NTR should facilitate 
functional genetic analysis in mouse models. We 
will conditionally under-express p75NTR using a 
mouse with Cre recombinase protein mediated by 
the GAP-43 promoter. The Cre mouse will then be 
crossed with another mouse containing a loxP 
flanked p75NTR gene with tetracycline-controlled 
expression. The mice will be deficient in p75NTR 
expression, except as mediated by the Cre/loxP 
system.  
In order to create conditional over-
expression of p75NTR in an injured neuronal cell, 
we will use the CNS growth-associated gene 
promoter (GAP-43; Zhang, 2005) with a 
tetracycline inducible Cre system (Sun, Chen, and 
Xiao, 2007) to allow for spatial and temporal 
control of p75NTR expression in vivo. In this case 
a conditional over-expression of p75NTR should 
facilitate functional genetic analysis in mouse 
models. To conditionally over-express p75NTR, a 
mouse with the Cre recombinase mediated by the 
GAP-43 promoter will be crossed with a mouse 
containing a p75NTR gene with the Tet-off 
system. The coding region of this gene will be 
separated from its promoter by a floxed ‘stop’ 
segment, which would be excised in the presence 
of active Cre recombinase. In this model, native 
p75NTR gene is expressed normally by the mouse 
along with the Cre/loxP gene when activated. 
Predictions: Conditional under-expression of p75NTR should 
promote neuron cell death after injury and conditional over-
expression of p75NTR should promote neuron survival after 
cell death. We project that in tissues in which p75NTR is 
under expressed we will ascertain that neuron survival is 
limited or non-existent. In tissues in which p75NTR is over-
expressed we will ascertain that neurons are surviving in 
vivo. Lack of regeneration in vivo, but presence of neuron 
survival in vitro, would suggest that growth and survival 
represent independent signaling pathways, the former, 
p75NTR would not influence. Lack of regeneration and 
neuron survival would imply greater activation of p75NTR by 
NGF/NO, as mentioned in AIM 1 Predictions. 
 
AIM 3: To manipulate expression and activation of p75NTR 
via injured in vitro PNS neuronal tissues. 
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1. Rationale:  Contrary to the CNS, damage to the 
PNS can be repaired. The expression of p75NTR 
is implicated in these regenerative capabilities by 
promoting neuron survival. Hence, if we over-
express P75NTR neuron survival should increase 
relative to baseline and under-expressed levels of 
p75NTR. We will perform in vitro experiments in a 
primary culture of cervical ganglion (SCG), and 
induced cultures of muscular dorsal root ganglion 
(DRG) cells and ciliary ganglia cells. Each culture 
represents functionally unique regions of the PNS 
known to express p75NTR. 
2. Design and Method:  We will 
independently culture DRG and ciliary ganglia 
cells. A primary culture of SCG cells will be 
purified from anesthetized, adult mouse brains. A 
3T3 cell line, which lacks p75NTR, will be used as 
a negative control. To establish baseline p75NTR 
expression levels using immunohistochemistry, we 
will perform in situ hybridization according to 
Corriveau, et. al. (1998) with rodent specific 
probes for anti-p75NTR, with an anti--actin probe 
as a positive control (DeFreitas, McQuillen, and 
Shatz, 2001). 
To produce p75NTR loss of function 
cells in the PNS, we will deplete p75NTR 
transcripts using siRNA sequences and plasmid 
transfection technique employed by Johnston, et 
al. (2007) as we did in the CNS. A randomized 
siRNA sequence vector will serve as a negative 
control. Preliminary p75NTR siRNA experiments 
will be preformed to determine the appropriate 
amount necessary to eliminate p75NTR. The cells 
will be tagged with mouse anti-p75NTR in order to 
confirm the transfection by immunoblotting with an 
anti-mouse monoclonal antibody. -actin will serve 
as a positive loading control (Johnston, et al., 
2007). In order to produce P75NTR gain of 
function, mutant cell lines will be transfected with 
p75NTR cDNA plasmids with an overactive CMV 
promoter. The p75NTR immunoblotting technique 
will confirm p75NTR over-expression.  
To assess whether over- or under-
expression of p75NTR effectively promotes 
neuron survival, we will co-culture each PNS cell 
line with and without either soluble MAG or pre-
cultured Schawnn cells (Tebu-Bio). These will be 
paired with or without the addition of soluble NGF 
(Dupuis, et al., 2008). The addition of soluble brain 
derived neurotrophic factor (BDNF) and neurotoxic 
kainic acid (KA) to each control culture will serve 
as respective positive and negative controls for 
cell survival (Young, et al., 1999; Brooke, et al., 
1999). We will assess neuron survival using a 2,3'-
azino-bis(ethylbenzothiazoline-6-sulphonic acid) 
enzyme-linked immunoabsorbant assay 
(ABT/ELISA) and a CellTiterGlo ATP assay. We 
will conduct two-way analysis of variance 
(ANOVA) using SPSS 13.0 data analysis software 
to compare neuron survival between p75NTR 
expression and ligand co-culture conditions.  
Predictions:  It is expected that if p75NTR expression is 
eliminated, then there will be a significant decrease in 
neuron regeneration. If p75NTR expression is increased, it is 
expected that there will be a significant amount of neuron 
regeneration. However, if there is not a significant amount of 
neuron survival seen after p75NTR expression is increased, 
it might mean that there is an alternate pathway that is 
promoting regeneration. 
 
AIM 4: To manipulate expression and activation of p75NTR 
via in vivo PNS mouse models. 
1. Rationale:  To further test p75NTR’s effect on 
neuron survival our research uses a conditional 
knockout and over-expression mouse model for 
p75NTR so as to examine peripheral nervous 
system neuronal cells in vivo. The Cre/loxP 
system is a way to conditionally knockout or over-
express genes in a site specific and time specific 
fashion to prevent lethality or other complications 
that occur in mice with conventional knockouts 
(Neumann, 1998). The Cre/lox system has the 
advantage of working in almost every cell type 
demonstrating its complete versatility and 
usefulness in this experiment. Contrary to our 
hypothesis, decreased cell survival upon p75NTR 
over-expression would suggest greater NGF than 
MBGI binding to p75NTR. A stronger p75NTR 
binding affinity by NGF than MBGIs would explain 
such alternative results. 
2. Design and Method: 
a) Injury and Analysis: Tetracycline will be injected 
into the crossed Cre/loxP mouse model one day 
prior to injury in order to induce knockout of 
p75NTR. A spinal chord dorsal hemisection (Li 
and Strittmatter, 2003) will be performed in order 
to injure the CNS of the Cre/loxP crossed mouse 
models five days after birth. 
To assess whether over- or under-
expression of p75NTR effectively promotes 
neuron survival, we will co-culture the p75NTR 
depleted and p75NTR gain of function neurons 
with exogenous sources of apoptotic factors NGF 
and NO, as well as either an artificial or natural 
source of myelin-based growth inhibitor (MBGI), 
soluble Nogo-A or oligodendrocytes, respectively 
(Dupuis, et al., 2008). The addition of soluble brain 
derived neurotrophic factor (BDNF) and neurotoxic 
kainic acid (KA) to cultures are respectively 
positive and negative cell survival controls 
(Brooke, 1999; Young, Bilsand, and Harper, 
1999). We will assess neuron survival three, five 
and seven days after injury using a 2,3'-azino-
bis(ethylbenzothiazoline-6-sulphonic acid) 
enzyme-linked immunoabsorbant assay 
(ABT/ELISA) and CellTiterGlo ATP assay. We will 
conduct multivariate analysis of variance 
(MANOVA) using SPSS 13.0 data analysis 
software to compare neuron survival dependence 
on time, p75NTR expression, and ligand co-
culture conditions.  
b) Cre/loxP Mouse Models:  To produce a conditional 
knockout of p75NTR in a mouse model, we will 
use the nestin promoter (Kramer, et al., 2006) with 
a tetracycline inducible Cre system (Sun, Chen, 
and Xiao, 2007) to allow for spatial and temporal 
control of p75NTR expression in vivo. In this case 
a conditional knockout of p75NTR should facilitate 
functional genetic analysis in mouse models. We 
will conditionally under express p75NTR using a 
mouse with Cre recombinase protein mediated by 
the GAP-43 promoter. The Cre mouse will then be 
crossed with another mouse containing a loxP 
flanked p75NTR gene with tetracycline-controlled 
expression. The mice will be deficient in p75NTR 
expression, except as mediated by the Cre/loxP 
system.  
In order to create conditional over-
expression of p75NTR in an injured neuronal cell, 
we will again use the nestin promoter (Kramer, et 
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al., 2006) with a tetracycline inducible Cre system 
(Sun, Chen, and Xiao, 2007) to allow for spatial 
and temporal control of p75NTR expression in 
vivo. In this case a conditional over-expression of 
p75NTR should facilitate functional genetic 
analysis in mouse models. To conditionally over-
express p75NTR, a mouse with the Cre 
recombinase mediated by the GAP-43 promoter 
will be crossed with a mouse containing a p75NTR 
gene with the Tet-off system (Sun, Chen, and 
Xiao, 2007). The coding region of this gene will be 
separated from its promoter by a floxed ‘stop’ 
segment, which would be excised in the presence 
of active Cre recombinase. In this model, native 
p75NTR gene is expressed normally by the mouse 
along with the Cre/loxP gene when activated. 
Predictions:  Conditional under-expression of p75NTR 
should promote neuron cell death after injury and conditional 
over-expression of p75NTR should promote neuron survival 
after cell death. We project that in tissues in which p75NTR 
is under-expressed we will ascertain that neuron survival is 
limited or non-existent. In tissues in which p75NTR is over-
expressed we will ascertain that neurons are surviving in 
vivo. Lack of regeneration in vivo, but presence of neuron 
survival in vitro would suggest that growth and survival 
represent independent signaling pathways, the former, 
p75NTR would not influence. Lack of regeneration and 
neuron survival would imply greater activation of p75NTR by 
NGF/NO, as mentioned in AIM 1 Predictions. 
 
Note: Eukaryon is published by students at Lake Forest 
College, who are solely responsible for its content. The 
views expressed in Eukaryon do not necessarily reflect 
those of the College. Articles published within Eukaryon 
should not be cited in bibliographies. Material contained 
herein should be treated as personal communication and 
should be cited as such only with the consent of the author. 
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